-

High-Risk Smoldering Multiple Myeloma Highlights from ASH 2022
High-Risk Smoldering Multiple Myeloma Highlights from ASH 2022 Patient advocate Jack Aiello and hematologist Dr. Shaji Kumar discuss what high-risk smoldering patients can do to delay or possibly avoid progression to active myeloma.
-

Diverse Myeloma Treatment Options Through Clinical Trials
Explore how clinical trials are creating more personalized, effective treatment options for people with multiple myeloma in this discussion with Dr. Ajai Chari (UC San Francisco) and patient advocate Bryon Daily (The Leukemia & Lymphoma Society).
-

Multiple Myeloma 101: Causes, Types, and Stages
Multiple Myeloma 101: Causes, Types, and Stages Not all cancers are created equally. Even though they might be similar in nature — i.e. uncontrolled division of abnormal cells in a part of the body — they’re not all treated the same way. Myeloma is a cancer of the plasma cells that sees about 200,000 US…
-

Ray’s Multiple Myeloma Story
Ray H., Multiple Myeloma, Stage 3 Symptoms: Hemorrhoids, low red blood cell count Treatments: Immunotherapy, chemotherapy, stem cell transplant
-

Multiple Myeloma Screening | Rafael Fonseca, MD
Learn about emerging multiple myeloma treatments from myeloma expert Dr. Rafael Fonseca.
-

Multiple Myeloma Screening | Joseph Mikhael, MD
Multiple Myeloma Screening Dr. Joseph Mikhael discusses exciting advances in multiple myeloma screening, including new information from the iSTOP and PROMISE clinical trials.
-

Relapsed Refractory Multiple Myeloma Treatments
Relapsed Refractory Multiple Myeloma Treatments Dr. Krina Patel, MD Anderson & Dr. Muhamed Baljevic, UNMC From new FDA-approved drugs and combinations to the latest in immunotherapy, there is a lot shifting in the landscape of relapsed/refractory multiple myeloma. The Patient Story is excited to present our latest event that features top multiple myeloma experts: Dr.…
-

What is Multiple Myeloma | Rafael Fonseca, MD
What is Multiple Myeloma? Hear from myeloma specialist, Dr. Rafael Fonseca of Mayo Clinic, who talks about multiple myeloma basics, including the different types and treatment options.
-

Dr. Irene Ghobrial, Multiple Myeloma
Irene Ghobrial, MD Role: Clinical investigator and professor of hematological oncology Focus: Multiple myeloma, Waldenström’s Macroglobulinemia, early screening, clinical trialsProvider:Dana-Farber Cancer Institute (Boston)
